Navigation Links
Swedish-American Life Science Summit (SALSS) to Address Major Issues Including Healthcare Reform, Synthetic Biology and Innovative Financing for Biotechs
Date:8/17/2009

life sciences research communities -- US and Sweden -- and engaging their thought leaders in wide-ranging discussions, SALSS once again expects to be a major catalyst for understanding and profiting from cutting edge developments in life sciences."

Members of the press wishing to attend the conference or conduct specific interviews with key speakers please contact Project Manager Claudia Olsson +46 (0) 702 792 524 or email claudia@swedishamericanlifescience.com. For conference details please contact Program Advisor Udayan Gupta +1 917 497 8407 or email udayangupta115@gmail.com. Or, contact Leslie Wolf-Creutzfeldt of Grayling, 646-284-9472, or fax: 646-284-9485.

ABOUT SALSS 2009

SALSS has an invitation-only format that features some of the best known Life Science Executives in the industry. Previous SALSS participants have included; Mr. Frederick Frank, former Vice Chairman <
'/>"/>

SOURCE The Swedish-American Life Science Summit
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
6. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
7. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
8. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
9. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...rsity Belfast are developing new sensors to detect... in the fight against the threat of terrorist atta...,swipe, an individual or crime scene to gather a s...ent that can detect the presence of chemicals with...ns to be made in response to terrorist threats. ,...
(Date:11/18/2009)...v. 18 Masimo (Nasdaq: ... Measure-Through Motion and Low-Perfusion pulse ox...i.H.A., one of the largest healthcare Group Purcha...ulti-year purchasing agreement for "gold standard"...t offers preferred contract pricing to Uni.H.A.,s ...
(Date:11/18/2009)...v. 18 /PRNewswire-FirstCall/ - YM BioSciences Inc....uct development company that identifies and advanc... products at various stages of development, announ...ab were presented today in a poster at the 2009 AA...tics conference in Boston, Massachusetts. The repo...
(Date:11/18/2009)...tly reduces key cardiac enzymes at multiple time p...rican Heart Association 2009 Scientific Sessions ,...rapeutics Inc., a biotechnology company pioneering...apeutics derived from pathogens, today reported re...T-111 (Serp-1), an anti-inflammatory protein deriv...
Breaking Biology Technology:New technology detects chemical weapons in seconds 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4
...nce at the EuroPCR08 will highlight choice of diff...tegrated imaging platform., SAN DIEGO, and BRUSSE... VOLC ), a leading manufacturer and developer of,i...ment (FM) and Optical,Coherence Tomography (OCT) p...tment of coronary and peripheral vascular disease,...
...ORK and PARSIPPANY, N.J., May 12 Forest,Laborator...al company, and,Daiichi Sankyo, Inc. today announc...reement for AZOR(TM)* (amlodipine and olmesartan m...of two antihypertensives, the,calcium channel bloc...or,blocker olmesartan medoxomil. Forest will recor...
...ference Call at 10:30 a.m. ET, May 13 -, EMERYVIL...Inc. (NTI(R)) (Nasdaq: NTII ) today announced fin...e nine months ended March 31,2008., Revenues for ...llion,compared to $4.9 million for the same three ...ses were $5.9 million for the third,quarter of 200...
Other Biology Technology:Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 2Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 3Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 4Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 2Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 3Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 4Neurobiological Technologies Reports Third Quarter Financial Results 2Neurobiological Technologies Reports Third Quarter Financial Results 3Neurobiological Technologies Reports Third Quarter Financial Results 4Neurobiological Technologies Reports Third Quarter Financial Results 5
(Date:11/20/2009)...Research Center (ERC) has been awarded a grant fro...ethods of recovering and reusing the heat that wou...ression process in a carbon capture system. The go... capture and sequestration, or storage (CCS), and ...emitted into the atmosphere by coal-fired power pl...
(Date:11/19/2009)...which cultivate fungus for food, have many remarka... list: the ant farmers, like their human counterpa...eir gardens grow. The finding, reported this week ...eviously unknown symbiosis between ants and bacter...have come to dominate the American tropics and sub...
(Date:11/19/2009)...A four-year, multi-institutional effort co-led by ...sts culminated today in publication of a landmark ...g in unprecedented detail the DNA sequence of maiz...called by North American consumers, is one of the ...e agricultural crop grown in the United States, re...
Breaking Biology News(10 mins):Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Like humans, ants use bacteria to make their gardens grow 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4China Pharma Holdings Inc to Report Second Quarter 2009 Financial Results on August 12 2009 53068 1China Pharma Holdings Inc to Report Second Quarter 2009 Financial Results on August 12 2009 53068 2Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America 53066 1Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America 53066 2Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America 53066 3Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America 53066 4Patriot Scientific Corporation Announces Cardiac Science Corporations Purchase of a Moore Microprocessor Patent 28TM 29 Portfolio License 53064 1Patriot Scientific Corporation Announces Cardiac Science Corporations Purchase of a Moore Microprocessor Patent 28TM 29 Portfolio License 53064 2
... young gene known as sphinx is inactivated in the ...courtship, scientists report in the May 27, 2008, ...f Sciences. , High levels of male-male courtship ...sophila melanogaster, the tiny insect that has bee...entury. , In 2002, the research team of Manyuan ...
...mproved resolution, tissue-specific molecular mark...gist James A. Weston and colleagues have possibly ...igin of embryonic cells that give rise to connecti...skull and facial structures in back-boned creature...om the Max Planck Institute of Immunology in Germa...
...ON, Mich.---Armed with chainsaws and pry bars, Uni...es recently hastened the end for nearly 7,000 matu...rm experiment to glimpse the Great Lakes region,s ...m each tree to kill it without cutting it down. , ...Forest Accelerated Succession Experiment (FASET) i...
Other Biology News:Courtship pattern shaped by emergence of a new gene in fruit flies 2Origin of cells for connective tissues of skull and face challenged 2Origin of cells for connective tissues of skull and face challenged 3U-M scientists remove thousands of aspens to glimpse forest's future 2U-M scientists remove thousands of aspens to glimpse forest's future 3
Peptone from Sigma-Aldrich
SmartSpec 3000 Spectrophotometer from Bio-Rad
Propidium Iodide Staining Solution Solution from BD Biosciences Pharmingen
BD Biocoat Matrigel Matrix Thin Layer 35 mm Culture Dishes from BD Biosciences - Discovery Labware
Biology Products: